• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Ling,YUAN Yanling.Research progress of biomimetic carriers based on cell membranes for brain targeted drug delivery[J].Journal Of Pharmaceutical Research,2025,44(5):497-506[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1926times   Download 762次 QR Code for this article
Scan with your phone!
基于细胞膜的仿生载体应用于脑靶向递药的研究进展
王玲,袁雁苓
Font:Larger+|Default|Smaller-
(四川大学华西医院临床药学部,四川 成都 610041)
摘要:
脑肿瘤、缺血性中风、阿尔茨海默病和帕金森病等脑部疾病的发病率逐年上升,严重威胁着人类健康,而血脑屏障(BBB)和血肿瘤屏障(BTB)的存在限制了药物进入大脑内部,并在肿瘤部位发挥药效。因此,开发安全有效的治疗方法为脑部疾病的治疗提供了新的机会。与治疗其他疾病一样,药物跨越预期的生物屏障需要考虑不会损伤正常组织并保持原本的活性。我们探讨了各种仿生修饰纳米载体在靶向脑部递送中的应用进展,包括内源性仿生纳米递送载体、外源性仿生纳米递送载体以及溶瘤病毒等其他仿生纳米递送系统的应用,为开发针对脑部疾病的靶向策略提供了新的思路。
关键词:  脑靶向  血脑屏障  细胞膜仿生载体  研究进展
DOI:10.13506/j.cnki.jpr.2025.05.013
基金项目:
Publication Date:May 25, 2025
Research progress of biomimetic carriers based on cell membranes for brain targeted drug delivery
WANG Ling,YUAN Yanling
(Department of Pharmacy,West China Hospital of Sichuan University, Chengdu 610041, China)
Abstract:
The incidence of brain diseases such as brain tumors, ischemic stroke, Alzheimer’s disease, and Parkinson's disease is increasing year by year, posing a serious threat to human health. However, the presence of the blood-brain barrier (BBB) and blood-tumor barrier (BTB) restricts the entry of drugs into the brain and their therapeutic effects at tumor sites. Therefore, the development of safe and effective therapeutic approaches provides new opportunities for the treatment of brain diseases. Similar to the treatment of other diseases, the translocation of drugs across anticipated biological barriers necessitates considerations to ensure non-damage to normal tissues while preserving their inherent activity. In this review, we have explored the advancements in the application of various biomimetic-modified nanocarriers for targeted delivery to the brain, including endogenous biomimetic nanocarriers, exogenous biomimetic nanocarriers, and other biomimetic nanodelivery systems such as oncolytic viruses. These findings provide new insights into the development of targeted strategies for brain diseases.
Key words:  Brain targeting  Blood brain barrier  Biomimetic nanocarriers  Research progress
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.